Home » Topics » Regulatory » Patents

Patents
RSS

Subtype-selective 5-HT1 antagonists from Pierre Fabre

Feb. 20, 1997

PFT inhibitors described by Warner-Lambert

Feb. 20, 1997

Zambon discloses ACE/NEP inhibitors

Feb. 20, 1997

Antifungals from Schering-Plough

Feb. 20, 1997

Akzo reports peptides for specific tolerance therapy

Feb. 20, 1997

SKB prepares chimeric leptins

Feb. 20, 1997

Antitumor heterocyclic compounds from Takeda

Feb. 20, 1997

Schering AG investigates vitamin D derivatives

Feb. 20, 1997

GRC-active agents from CoCensys modulate brain excitability

Feb. 19, 1997

Antiarrhythmic agents from Merck & Co.

Feb. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...